NEW YORK, July 15, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Perrigo Company plc ("Perrigo") (NYSE: PRGO) between April 21, 2015 and May 11, 2016. This action is also brought on behalf of all investors in Perrigo common stock as of November 13, 2015, the deadline for Perrigo investors to tender their shares in connection with a tender offer made by Mylan N.V. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the District of New Jersey. To get more information go to:

http://www.zlk.com/pslra/perrigo-company-plc

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that Perrigo made false and/or misleading statements about its financial condition and growth prospects in an effort to convince shareholders to reject a merger proposal by Mylan N.V.

On April 8, 2015, Mylan N.V. offered to purchase Perrigo for $205 per share. Then on April 21, 2015, Perrigo rejected the offer and told investors that the offer undervalued Perrigo. Then on November 13, 2015, a majority of Perrigo's shareholders declined to tender their shares, thus defeating Mylar's tender offer. Since the defeat of this offer, Perrigo's CEO has resigned, it has lowered its 2016 earnings guidance, and incurred a $185 million impairment charge related to its acquisition of Omega Pharma NV.

If you suffered a loss in Perrigo you have until July 18, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.